Hepatitis C virus infection diagnosis using metabonomics

Area of Science:

• Biochemistry
• Medical Diagnostics
• Metabolomics

Background:

• Metabonomics, utilizing Nuclear Magnetic Resonance (NMR), identifies low molecular weight endogenous metabolites in biofluids as 'metabolic fingerprints' indicative of disease.
• These metabolic fingerprints offer a diagnostic approach for various pathological conditions.

Purpose of the Study:

• To apply metabonomics for identifying hepatitis C virus (HCV) infection.
• To analyze ¹H NMR spectra of urine samples combined with multivariate statistical methods for diagnostic purposes.

Main Methods:

• A pilot study involved 34 patients with HCV infection and 32 healthy controls.
• Urine samples were analyzed using ¹H NMR spectroscopy.
• Multivariate statistical methods, including Principal Component Analysis (PCA) and Discriminant Analysis (DA), were employed for classification.

Main Results:

• The metabonomics model correctly identified 32 out of 34 HCV-positive patients and 31 out of 32 controls.
• The model demonstrated a sensitivity of 94%, specificity of 97%, positive predictive value of 97%, and negative predictive value of 94%.
• Overall accuracy was 95% (P < 0.001).

Conclusions:

• Metabonomics based on ¹H NMR urine spectra effectively discriminated patients with HCV infection in this preliminary study.
• The developed model exhibits high sensitivity and specificity, indicating its potential as a valuable tool in medical practice for HCV diagnosis.